Literature DB >> 12871192

Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications.

Alejandro Ruiz-Argüelles1, Liliana Rivadeneyra-Espinoza, Donato Alarcón-Segovia.   

Abstract

The dogmatic and at one time prevalent concept that intact antibody molecules were not able to enter into viable cells has now been modified due to the availability of a large amount of experimental findings and clinical observations that indicate otherwise. Penetration of mature autoantibodies into living cells might participate in the pathogenesis of diverse autoimmune diseases, through inducing apoptosis of healthy tissues and cells, but also by contributing to the breakdown of self-tolerance through presentation of self-antigens to the immune system. Conversely, the penetration of naturally occurring autoantibodies into immature lymphoid cells might have a physiological role in the edition of the immune repertoire in healthy individuals. Increasing interest is being paid to the potential immunotherapeutic role of penetrating antibodies as tools to deliver drugs, isotopes or genes into cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871192     DOI: 10.2174/1381612033454379

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  11 in total

1.  Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo.

Authors:  S Sanchez-Sosa; M Aguirre-Lombardo; G Jimenez-Brito; A Ruiz-Argüelles
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

2.  Nuclear-targeting autoantibodies induced nuclear PARP cleavage accompanied by more pronounced decrease of peripheral white blood cells than Ro/SSA and La/SSB antigen-targeting autoantibodies.

Authors:  Ingrid Böhm
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

3.  IgG deposits can be detected in cell nuclei of patients with both lupus erythematosus and malignancy.

Authors:  Ingrid Böhm
Journal:  Clin Rheumatol       Date:  2007-03-16       Impact factor: 2.980

4.  Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE.

Authors:  Mirjana Pavlovic; Anna Kats; Michelle Cavallo; Ran Chen; James X Hartmann; Yehuda Shoenfeld
Journal:  Autoimmune Dis       Date:  2010-07-20

Review 5.  Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Clin Dev Immunol       Date:  2012-06-14

6.  Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin.

Authors:  Aggeliki D Sali; Ioannis Karakasiliotis; Maria Evangelidou; Stratis Avrameas; Peggy Lymberi
Journal:  Clin Transl Immunology       Date:  2015-10-02

Review 7.  Targeted Intracellular Delivery of Antibodies: The State of the Art.

Authors:  Tatiana A Slastnikova; A V Ulasov; A A Rosenkranz; A S Sobolev
Journal:  Front Pharmacol       Date:  2018-10-24       Impact factor: 5.810

8.  Gene silencing by cell-penetrating, sequence-selective and nucleic-acid hydrolyzing antibodies.

Authors:  Woo-Ram Lee; Ji-Young Jang; Jeong-Sun Kim; Myung-Hee Kwon; Yong-Sung Kim
Journal:  Nucleic Acids Res       Date:  2009-12-09       Impact factor: 16.971

9.  Peptide Sharing Between Viruses and DLX Proteins: A Potential Cross-Reactivity Pathway to Neuropsychiatric Disorders.

Authors:  Guglielmo Lucchese; Benjamin Stahl
Journal:  Front Neurosci       Date:  2018-03-21       Impact factor: 4.677

Review 10.  Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions.

Authors:  Yu Tang; Yanguang Cao
Journal:  Pharmaceutics       Date:  2021-03-21       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.